Evidence map›Paper›PMID 39799291›Full record

ArticleBMC public health2025

Young, Empowered & strong (YES): a study protocol paper for a randomized controlled trial of an mHealth symptom monitoring and self-management intervention for adolescent and young adult (AYA) breast cancer survivors.

Kate E Dibble, Shoshana M Rosenberg, Craig Snow, Gregory J Kirkner, Nabihah Tayob, Magnolia Contreras, Noel D Roma, Cecilia R DeGraffinreid, Timiya S Nolan, Dawn L Hershman and 2 more

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04906200 (Randomized Controlled Trial of Young, Empowered &Amp; Strong), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04906200 naactive not recruitingnot on this map

Randomized Controlled Trial of Young, Empowered &Amp; Strong (YES), a Web-Based Patient-Reported Symptom Monitoring and Self-Management Portal for Adolescent and Young Adult Breast Cancer Survivors

TypeinterventionalSponsorOhio State University Comprehensive Cancer CenterRan2021 to 2026Enrolled400ConditionsAnatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8ArmsBest Practice, Internet-Based Intervention, Survey Administration
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Determining the feasibility of self-administered relaxing acupressure for fatigue among adolescent and young adult cancer survivors.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kate E Dibble *Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Shoshana M Rosenberg *Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.
Craig SnowDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Gregory J KirknerDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Nabihah TayobDepartment of Medicine, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02215, USA.
Magnolia ContrerasDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Noel D RomaDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Cecilia R DeGraffinreidDepartment of Medicine, Division of Cancer Prevention & Control, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
Timiya S NolanHeersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Dawn L HershmanDepartment of Medicine and Epidemiology, Columbia University Irving Medical Center, Herbert Irving Comprehensive Cancer Center, New York, NY, USA.
Michelle Naughton *Department of Medicine, Division of Cancer Prevention & Control, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
Ann H Partridge *Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. ann_partridge@dfci.harvard.edu.

Funding

A web-based patient-reported symptom monitoring and self-management portal for adolescent and young adult breast cancer survivorsU01CA246648 · NCI · DANA-FARBER CANCER INST · PI NAUGHTON, MICHELLE J., PARTRIDGE, ANN H · 2020 to 2024
$3.7M
Piloting Y-AMBIENT: A Quality of Life Intervention for Young African American Breast Cancer Survivors in TreatmentK08CA245208 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI NOLAN, TIMIYA S · 2020 to 2024
$895k
American Cancer Society CRP-24-1187963-01-PROFBreast Cancer Research Foundation BCRF-23-124NCI NIH HHS K08 CA245208NCI NIH HHS U01 CA246648NCI NIH HHS U01CA246648
6 · The paper itself

Abstract

backgroundCompared to older adults with breast cancer (BC), adolescents and young adults (AYAs) develop more aggressive disease necessitating more intensive therapy with curative intent, which is disruptive to planned life trajectories. The burden of unmet needs among AYA BC survivors exists in two domains: (1) symptoms (e.g., sexual problems, anxiety, fatigue, stress, hot flashes) and (2) AYA concerns (e.g., fertility, genetics, relationships, economic attainment). Improved attention to concerns and symptoms may improve symptom management and quality of life. The Young, Empowered and Strong (YES) trial tests the efficacy of a 9-month, multicomponent digital health intervention that includes monthly assessments of prevalent symptoms, a chat room, and journal to engage and support AYAs with BC by providing tailored information, resources, and support outside of the clinical setting.

methodsYES is a multicenter, randomized controlled trial across three academic institutions in the United States with 400 participants randomized to either the YES intervention or usual care arm. Inclusion criteria include biologically female; 15-39 years of age at diagnosis of stage 0-III BC; within 3 years of diagnosis; no known evidence of recurrence; no prior history of new malignancy since initial BC diagnosis; and ability to access medical records from treatment site. All participants complete REDCap surveys at baseline, and at 3, 6, and 9 months post-enrollment. The primary outcome is quality of life as measured by the Quality of Life in Adult Cancer Survivors Scale (QLACS), with changes from baseline to 6-months in QLACS scores, compared by arm. Secondary outcomes include patient reported AYA concerns/needs, emotional symptoms, general health, physical symptoms, and health behaviors, DISCUSSION: Study findings will provide valuable insight into the ability of the YES digital health intervention to address symptoms and concerns of AYA BC survivors and assist them to track and self-manage their own symptoms, concerns, and needs related to their cancer outside of the clinic.

trial registrationClinicaltrials.gov, NCT04906200, registered May 13, 2021.

Indexed as

Breast NeoplasmsCancer SurvivorsSelf-ManagementTelemedicineAdolescentAdultFemaleHumansMulticenter Studies as TopicQuality of LifeRandomized Controlled Trials as TopicYoung AdultAdolescent and young adultsBreast cancermHealthOncologySurvivorship

Identifiers

PMID39799291
PMCPMC11724548

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.